SGN-CD123A

· Seagen Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGN-CD123A, covering 2018-05-14 to 2018-05-14. Get the full timeline:

Most recent: Clinical Trial Update: A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia [Phase 1]